This topic contains a solution. Click here to go to the answer

Author Question: A patient is being treated with isoniazid (INH), rifampin, and pyrazinamide in phase I of treatment ... (Read 46 times)

sabina

  • Hero Member
  • *****
  • Posts: 563
A patient is being treated with isoniazid (INH), rifampin, and pyrazinamide in phase I of treatment for tuberculosis. The organism develops resistance to isoniazid. Which drug will the nurse anticipate the provider will order to replace the isoniazid?
 
  a. Ciprofloxacin (Cipro)
  b. Ethambutol (Myambutol)
  c. Kanamycin
  d. Streptomycin sulfate

Question 2

Which person should be treated with prophylactic antitubercular medication?
 
  a. A child who attends the same school with a child who has tuberculosis
  b. A nurse who is working in a hospital
  c. An individual who is HIV-positive with a negative TB skin test
  d. A patient who has close contact with someone who has tuberculosis



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

makaylafy

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

ANS: B
If there is bacterial resistance to isoniazid, the first phase may be changed to ethambutol, rifampin, and pyrazinamide. Ciprofloxacin, kanamycin, and streptomycin are not generally first-line antitubercular drugs.

Answer to Question 2

ANS: D
Personal contact with a person having a diagnosis of tuberculosis is required to indicate prophylactic treatment with antitubercular therapy. Attending the same school does not necessarily mean close contact occurs. Health care professionals do not need prophylactic treatment. HIV-positive individuals with negative TB skin tests do not need prophylaxis.




sabina

  • Member
  • Posts: 563
Reply 2 on: Jul 23, 2018
Excellent


patma1981

  • Member
  • Posts: 292
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Multiple sclerosis is a condition wherein the body's nervous system is weakened by an autoimmune reaction that attacks the myelin sheaths of neurons.

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library